AU2001244572A1 - Microsphere preparations containing neurokinin 1 receptor antagonist - Google Patents
Microsphere preparations containing neurokinin 1 receptor antagonistInfo
- Publication number
- AU2001244572A1 AU2001244572A1 AU2001244572A AU4457201A AU2001244572A1 AU 2001244572 A1 AU2001244572 A1 AU 2001244572A1 AU 2001244572 A AU2001244572 A AU 2001244572A AU 4457201 A AU4457201 A AU 4457201A AU 2001244572 A1 AU2001244572 A1 AU 2001244572A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonist
- preparations containing
- microsphere preparations
- neurokinin
- containing neurokinin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-93540 | 2000-03-30 | ||
JP2000093540 | 2000-03-30 | ||
PCT/JP2001/002530 WO2001074392A1 (en) | 2000-03-30 | 2001-03-28 | Microsphere preparations containing neurokinin 1 receptor antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001244572A1 true AU2001244572A1 (en) | 2001-10-15 |
Family
ID=18608713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001244572A Abandoned AU2001244572A1 (en) | 2000-03-30 | 2001-03-28 | Microsphere preparations containing neurokinin 1 receptor antagonist |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001244572A1 (en) |
WO (1) | WO2001074392A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200529890A (en) * | 2004-02-10 | 2005-09-16 | Takeda Pharmaceutical | Sustained-release preparations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583134A (en) * | 1992-09-30 | 1996-12-10 | Sanofi | 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present |
JPH10203966A (en) * | 1996-11-21 | 1998-08-04 | Takeda Chem Ind Ltd | Sustained release microcapsule and its production |
JP4308933B2 (en) * | 1997-12-12 | 2009-08-05 | あすか製薬株式会社 | Microsphere formulation containing dolastatin 10 derivative |
-
2001
- 2001-03-28 WO PCT/JP2001/002530 patent/WO2001074392A1/en active Application Filing
- 2001-03-28 AU AU2001244572A patent/AU2001244572A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001074392A1 (en) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4802500A (en) | 2-aminoquinolinecarboxamides: neurokinin receptor ligands | |
AU2143295A (en) | Neurokinin receptor antagonists | |
AU3243300A (en) | Multiparticulate formulation | |
AU5440996A (en) | 2-acylaminopropanamides as tachykinin receptor antagonists | |
AU5333596A (en) | 3-benzylamino-2-phenylpiperidines as neurokinin antagonists | |
AU2002210782A1 (en) | Amide derivatives as nmda receptor antagonists | |
IL150033A0 (en) | Selective neurokinin antagonists | |
AU2001269876A1 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
AU1998200A (en) | Multiparticulate oral dosage forms | |
AP2001002376A0 (en) | Nmda receptor agonist pharmaceutical compositions | |
AU5095000A (en) | Receptor interacting protein rip3 | |
AU2001296013A1 (en) | Pgd2 receptor antagonistic pharmaceutical compositions | |
AU2001271435A1 (en) | Vitronectin receptor antagonist pharmaceuticals | |
AU2371400A (en) | Vitronectin receptor antagonist pharmaceuticals | |
AU2001290772A1 (en) | Alpha v integrin receptor antagonists | |
IL142045A0 (en) | Naphthalenecarboxamides as tachykinin receptor antagonists | |
AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
IL144299A0 (en) | N-triazolymethyl-piperazine derivatives as neurokinin receptor antagonists | |
IL134301A0 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
AU2002216079A1 (en) | Bombesin receptor antagonists | |
AU5764298A (en) | Tachykinin antagonists | |
AU2673201A (en) | Alpha-arylethylpiperazine derivatives as neurokinin antagonists | |
AU3611099A (en) | Oxindole derivatives used as neurokinin receptor antagonists | |
AU4999897A (en) | Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists | |
AU2001271018A1 (en) | Gpr14 antagonist |